Go Digit General Insurance Ltd (GODIGIT) Q1 FY27 Results Analysis: PAT Plunges 37.6%, Combined Ratio Worsens

CompoundingAI Research Updated July 23, 2026 2 min read
Negative

Go Digit General Insurance Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 2,359.36 Cr (+8.25% YoY) and PAT growth of -37.55% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 23, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 2,359.36 Cr (+8.25% YoY)
PAT (Q1)Rs. 86.39 Cr (-37.55% YoY)
EPS (Q1)Rs. 0.93 (-38.00% YoY)
Market capRs. 25,949.14 Cr
CMPRs. 280.85

Quarter Snapshot

Combined ratio deteriorated to 112.3% and PAT fell 37.55% YoY, driven by widening underwriting losses in Motor and Health Group segments. Positives include improved net retention and higher investment income, but near-term outlook remains challenging until motor corrective actions show results in Q2 FY27.

Key Investment Insights

Key Positives

  • Net Premium Written grew 7.36% YoY to Rs.2,094.19 Cr, driven by improved net retention ratio (76.7% vs 65.4% YoY).
  • Investment income grew 12.02% YoY to Rs.351.83 Cr, supported by higher AUM and yield.
  • Solvency ratio improved to 2.43x from 2.27x YoY, well above regulatory minimum.
  • Health Government segment underwriting profit rose 204.93% YoY to Rs.15.46 Cr.
  • Crop segment swung to underwriting profit of Rs.5.74 Cr from a loss of Rs.0.75 Cr YoY.

Risk Factors

  • Combined ratio deteriorated to 112.3% from 108.6% YoY, driven by higher claims and expense ratios.
  • Underwriting loss widened 45.68% YoY to Rs.282.01 Cr, primarily from Motor segment.
  • PAT fell 37.55% YoY to Rs.86.39 Cr, impacted by higher claims, expenses, and effective tax rate.
  • Health Group/Corporate underwriting loss more than doubled to Rs.51.43 Cr.
  • Effective tax rate rose to 25.17% from 13.90% YoY, adding to profit decline.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now